AYA ELSAADI

Physician Assistants & Advanced Practice Nursing Providers|Physician Assistant RICHMOND, TX NPI 1013687474

General Payments — all program years on this page

$532.85

  • Category: General Payments
  • Program years: PY2022–2024
  • Record count: 30
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $310.62 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $310.6215

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Lilly USA, LLC $90.974
Novo Nordisk AS $90.894
Astellas Pharma US Inc $67.713
Acerta Pharma LLC $29.432
ABBVIE INC. $15.931
Galderma Laboratories, L.P. $15.691

By program year

Program yearAmountRecords
2022 $17.871
2023 $204.3614
2024 $310.6215

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100378583 Novo Nordisk Inc $22.65 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100504547 Novo Nordisk Inc $20.50 01/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100518911 Novo Nordisk Inc $30.83 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100549098 Novo Nordisk Inc $16.91 05/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105514337 AstraZeneca Pharmaceuticals LP $14.87 04/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105590490 AstraZeneca Pharmaceuticals LP $14.56 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107070248 ABBVIE INC. $15.93 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135561344 Lilly USA, LLC $24.23 04/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135561346 Lilly USA, LLC $23.18 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135562484 Lilly USA, LLC $20.94 01/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135582470 Lilly USA, LLC $22.62 10/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139486758 Astellas Pharma US Inc $31.14 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139492248 Astellas Pharma US Inc $20.45 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139530848 Astellas Pharma US Inc $16.12 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145355925 Galderma Laboratories, L.P. $15.69 12/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.